$RNAC stock has now risen 7% today, according to our price data from Polygon. There has been approximately $13,436,180 of trading volume.
Here is what we see in our data on $RNAC (you can track the company live on Quiver's $RNAC stock page):
$RNAC Insider Trading Activity
$RNAC insiders have traded $RNAC stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $RNAC stock by insiders over the last 6 months:
- TIMOTHY C BARABE purchased 30,000 shares for an estimated $205,797
- CARSTEN BRUNN (President and CEO) sold 23,766 shares for an estimated $162,076
- BLAINE DAVIS (Chief Financial Officer) sold 10,591 shares for an estimated $72,227
- MILOS MILJKOVIC (Chief Medical Officer) sold 3,573 shares for an estimated $24,366
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RNAC Hedge Fund Activity
We have seen 37 institutional investors add shares of $RNAC stock to their portfolio, and 35 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 788,794 shares (-36.6%) from their portfolio in Q4 2025, for an estimated $5,687,204
- SIREN, L.L.C. removed 563,272 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $4,061,191
- MPM BIOIMPACT LLC removed 380,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $2,739,800
- PRIVIUM FUND MANAGEMENT B.V. added 172,500 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,243,725
- MILLENNIUM MANAGEMENT LLC added 139,009 shares (+548.2%) to their portfolio in Q4 2025, for an estimated $1,002,254
- BANK OF AMERICA CORP /DE/ added 99,023 shares (+703.8%) to their portfolio in Q4 2025, for an estimated $713,955
- MARSHALL WACE, LLP added 93,334 shares (+110.1%) to their portfolio in Q4 2025, for an estimated $672,938
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RNAC Analyst Ratings
Wall Street analysts have issued reports on $RNAC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 11/19/2025
- BTIG issued a "Buy" rating on 11/14/2025
To track analyst ratings and price targets for $RNAC, check out Quiver Quantitative's $RNAC forecast page.
$RNAC Price Targets
Multiple analysts have issued price targets for $RNAC recently. We have seen 3 analysts offer price targets for $RNAC in the last 6 months, with a median target of $42.0.
Here are some recent targets:
- Gil Blum from Needham set a target price of $42.0 on 01/09/2026
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $30.0 on 11/19/2025
- Julian Harrison from BTIG set a target price of $44.0 on 11/14/2025
You can track data on $RNAC on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
